Association of airway cathepsin B and S with inflammation in cystic fibrosis

Pediatric Pulmonology

Volumn 45, Issue 9, 2010, Pages 860-868

  Martin, S L ^a   Moffitt, K L ^a   McDowell, A ^b   Greenan, C ^a   Bright Thomas, R J ^c   Jones, A M ^c   Webb, A K ^c   Elborn, J S ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cathepsin; Cysteine proteinase; Cystic fibrosis; Inflammation; Neutrophil elastase

Indexed keywords

C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN S; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AIRWAY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CYSTIC FIBROSIS; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOBLOTTING; INFLAMMATION; LUNG FIBROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SPECTROPHOTOMETRY; SPUTUM ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CATHEPSIN B; CATHEPSINS; CYSTIC FIBROSIS; HUMANS; INFLAMMATION; LUNG DISEASES; SPUTUM; YOUNG ADULT;

EID: 77957288902     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21274     Document Type: Article

References (44)

1. Konstan MW, Berger M. Infection and inflammation of the lung in cystic fibrosis. In: Davis PB, editor. Cystic fibrosis. New York: Dekker; 1993. pp. 219-275.
2. Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF, Jr., Dearborn DG. Biochemical and pathological evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985;132:529-535. (Pubitemid 15247968)
3. Birrer P, McElvaney NG, Rucombining double acute accentdeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150:207-213.
4. Pham CTN. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Inmmunol 2006;6:541-550.
5. Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol 2008;40:1238-1245.
6. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000;192:789-799.
7. Wolters PJ, Raymond WW, Blount JL, Caughey GH. Regulated expression, processing and secretion of dog mast cell dipeptidyl peptidase I. J Biol Chem 1998;273:15514-15520.
8. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA. Cystatin C deficiency in human atheroschlerosis and aortic aneurysms. J Clin Invest 1999; 104:1191-1197.
9. Heidtmann HH, Salge U, Havemann K, Kirschke H, Wiederanders B. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. Oncol Res 1993;5:441-451.
10. Wolters PJ, Chapman HA. Importance of lysosomal cysteine proteases in lung disease. Respir Res 2000;1:170-177.
11. Bühling F, Groneberg D, Welte T. Proteases and their role in chronic inflammatory lung diseases. Curr Drug Targets 2006;7: 751-759. (Pubitemid 43827271)
12. Veillard V, Lecaille F, Lalmanach G. Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system? Int J Biochem Cell Biol 2008;40:1079-1094.
13. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepins B, L and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 1995;92:3849-3853.
14. Riese RJ, Wolf PR, Brocombining double acute accentmme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996;4:357-366.
15. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB, Jr., O'Neill S, McElvaney NG. Inactivation of human b-defensins 2 and 3 by elastolytic cathepsins. J Immunol 2003;171:931-937.
16. Rogan MO, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis 2004;190:1245-1253.
17. Taggart CC, Lowe GJ, Greene CM, Mulgrew AT, O'Neill SJ, Levine RL, McElvaney NG. Cathepsin B, L and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem 2001; 276:33345-33352. (Pubitemid 33659339)
18. Hawthorne SJ, Halton DW, Walker B. Identification and characterisation of the cysteine and serine proteinases of the trematode, Haplometra cylindracea and determination of their haemoglobinase activity. Parasitology 1994;108:595-601.
19. Zavasnik-Bergant T, Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 2006;67:349-355.
20. Green GDJ, Shaw E. Diazomehtyl ketones are specific inactivators of thiol proteinases. J Biol Chem 1981;256:1923-1928.
21. Jones AM, Govan JR, Doherty CJ, Dodd M, Isalska B, Stanbridge TN, Webb AK. Spread of a multi-resistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358: 557-558.
22. Jones AM, Martin L, Bright-Thomas RJ, Dodd ME, McDowell A, Moffitt KL, Elborn JS, Webb AK. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur Resp J 2003;22:503-506.
23. Watorek W, van Halbeek H, Travis J. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. Biol Chem Hoppe Seyler 1993;374:385-393.
24. Iacobuzio-Donahue CA, Shuja S, Cai J, Peng P, Murnane MJ. Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumour progression. J Biol Chem 1997;272:29190-29199.
25. Nissler K, Strubel W, Kreusch S, Rommerskirch W, Weber E, Wiederanders B. The half-life of human pro-cathepsin S. Eur J Biochem 1999;263:717-725.
26. Warfel AH, Cardozo C, Yoo OH, Zucker-Franklin D. Cathepsin B and cystatin C production by alveolar macrophages from smokers and non-smokers. J Leuk Biol 1991;49:41-47.
27. Serveau-Avesque C, Ferrer-Di Martino M, Hervé-Grépinet V, Hazouard E, Gauthier F, Diot E, Lalmanach G. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell 2006;98:15-22.
28. Perdereau C, Godat E, Maurel M-C, Hazouard E, Diot E, Lalmanach G. Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids. Biochim Biophys Acta 2006;1762:351-356. (Pubitemid 43172851)
29. Luthgen K, Ebert W, Trefz G, Gabrijelcic D, Turk V, Lah T. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect Prev 1993; 18:387-397.
30. Takeyabu K, Betsuyaku T, Nishimura M, Yoshioka A, Tanino M, Miyamoto K, Kawakami Y. Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J 1998;12:1033-1039. (Pubitemid 28545608)
31. Burnett D, Stockley RA. Cathepsin B-like proteinase activity in sputum and bronchoalveolar lavage samples: relationships to inflammatory cells and effects of corticosteroids and antibiotic treatment. Clin Sci 1985;68:469-474.
32. Buttle DJ, Burnett D, Abrahamson M. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum - relationship to inflammation. Scan J Clin Lab Invest 1990;50:509-516.
33. Watt AP, Courtney J, Moore J, Ennis M, Elborn JS. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005;60:659-664. (Pubitemid 41129064)
34. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med 1999;160:S49-S52.
35. Geraghty P, Rogan MP, Greene CM, Boxio RMM, Poiriert T, O'Mahony M, Belaaouaj A, O'Neill SJ, Taggart CC, McElvaney NG. Neutrophil elastase up-regulates cathepsin B and matrix metalloproteinase-2 expression. J Immunol 2007;178:5871-5878.
36. Li JH, Pober JS. The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J Immunol 2005;175:1858-1866.
37. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, Strauss JF III. Pro-inflammatory cytokines induce expression of matix-metabolising enzymes in human cervical smooth muscle cells. Am J Pathol 1999;154:1755-1762.
38. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327-2334. (Pubitemid 20138854)
39. Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ. Circulating immunoreactive IL-6 in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1764-1769.
40. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA., Cathepsin S regulates antigen presentation and immunity. J Clin Invest 1998; 101:2351-2363.
41. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ. CFTR regulates phagosomes acidification in macrophages and alters bactericidal activity. Nature Cell Biol 2006;8:933-944.
42. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997;59:63-68.
43. Buttle DJ, Bonner BC, Burnett D, Barrett AJ. A catalytically active high Mr form of cathepsin B from sputum. Biochem J 1988;254:693-699.
44. Berdowska I. Cysteine proteases as disease markers. Clin Chim Acta 2004;342:41-69.